{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/benzodiazepine-z-drug-withdrawal/prescribing-information/diazepam/","result":{"pageContext":{"chapter":{"id":"22b2c65a-e4c1-5d8f-9260-f639540d94cb","slug":"diazepam","fullItemName":"Diazepam","depth":2,"htmlHeader":"<!-- begin field 088630bd-ee91-47be-b51e-a965014f6eef --><h2>Diazepam</h2><!-- end field 088630bd-ee91-47be-b51e-a965014f6eef -->","summary":"","htmlStringContent":"<!-- begin item 67feae32-289e-4a87-a901-a965014f6e84 --><!-- end item 67feae32-289e-4a87-a901-a965014f6e84 -->","topic":{"id":"e3f1abb8-a968-53c3-bc6a-12e1b2886ed2","topicId":"35151ccb-5966-4e29-97a4-191f3f2aef6a","topicName":"Benzodiazepine and z-drug withdrawal","slug":"benzodiazepine-z-drug-withdrawal","lastRevised":"Last revised in January 2019","chapters":[{"id":"ddeb227b-ec5e-5a69-b033-23d16e492302","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ca1d0037-207c-5656-8c1a-64eb8f8a6adf","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4f9475f8-9d93-5b3d-9cc7-66f08d975494","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"33c4d415-a5bf-586c-af94-95833f29167f","slug":"changes","fullItemName":"Changes"},{"id":"814181c9-c71c-54f0-a9f2-a7b2a5f73459","slug":"update","fullItemName":"Update"}]},{"id":"2237f5ce-b47f-5f59-80d4-2098a2fafae1","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"14f4d723-2346-5509-b69f-ec1690c54f89","slug":"goals","fullItemName":"Goals"},{"id":"978d3882-5b77-58d0-9081-5f1879a2e244","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"df6950b2-9910-5c3e-9f7e-a89c359ba5cf","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f78c4bb6-5d1b-516c-acb6-5a8a6add79ec","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1d88ca0e-4d2b-56ae-9602-a213d4c8767e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"00453e06-07ba-5d13-a4f0-dfd3b6e7dfa4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"058ea4e2-b85f-5dbf-885b-f3a39f06d48c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"24a95463-c4af-5572-b06f-acf2f15c47d1","slug":"definition","fullItemName":"Definition"},{"id":"fbb9e10e-ed3c-51d5-b3fa-e2d482b83413","slug":"prevalance","fullItemName":"Prevalance"},{"id":"32dfcd69-3d5d-5897-bd8f-cee84b53b670","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d110deb7-70d0-5c76-8606-a9af49e97f91","slug":"complications","fullItemName":"Complications"},{"id":"c26626ad-6167-542c-98fe-a2ff03221e61","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a846d324-cab9-57dd-a619-3bf18b540356","fullItemName":"Management","slug":"management","subChapters":[{"id":"80278306-0d51-5a46-abdb-638c41fd825d","slug":"benzodiazepine-z-drug-withdrawal","fullItemName":"Scenario: Benzodiazepine and z-drug withdrawal"}]},{"id":"b14f0631-9202-58fa-a823-a1f92f05ac08","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"22b2c65a-e4c1-5d8f-9260-f639540d94cb","slug":"diazepam","fullItemName":"Diazepam"}]},{"id":"3833e4c8-dbff-59bf-92ae-bd1c772444bb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d4659376-3ee7-5273-9fe9-08f5ce86d7d8","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9bd84543-e92f-541d-80e5-17f0b36fcb90","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"d3ade608-7d7c-5174-9cad-8cecde797cd1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3e7141fe-bc43-5b07-81c4-1fb82ca82b2c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5c9aad6e-7321-5cc2-bad0-677e761afc6e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7a323840-12e0-545e-87de-461171f81997","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"351aac8e-ed32-587e-88b8-27ee3fa69f10","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b14f0631-9202-58fa-a823-a1f92f05ac08","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"133a4dd6-719b-5ef0-ab44-9a9d74101b53","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field cace49fc-d5c0-40ca-baf0-a965014f8008 --><h3>Contraindications and cautions</h3><!-- end field cace49fc-d5c0-40ca-baf0-a965014f8008 -->","summary":"","htmlStringContent":"<!-- begin item ba5b45e8-1fb9-42ce-abd4-a965014f7fd0 --><!-- begin field 46885dc4-243c-4720-b844-a965014f8008 --><ul><li><strong>Do not prescribe diazepam to people </strong><strong>with:</strong><ul><li>Current or a history of alcohol or opioid use or misuse — alcohol and opioids can induce lethal sedation by potentiating the effects of diazepam.</li><li>Acute porphyria.</li><li>Myasthenia gravis — condition may be aggravated.</li><li>Sleep apnoea — condition may be aggravated.</li><li>Bronchitis or chronic obstructive pulmonary disease.</li><li>Severe hepatic insufficiency — elimination half-life may be prolonged.</li><li>Major depression.</li><li>Phobic or obsessional states, psychosis or schizophrenia, hyperkinesis — paradoxical reactions may occur.</li></ul></li><li><strong>Prescribe diazepam with caution to:</strong><ul><li>People with personality disorders.</li><li>The elderly, due to the increased risk of falls — the manufacturer advises halving the recommended doses.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">ABPI Medicines Compendium, 2015</a>]</p><!-- end field 46885dc4-243c-4720-b844-a965014f8008 --><!-- end item ba5b45e8-1fb9-42ce-abd4-a965014f7fd0 -->","subChapters":[]},{"id":"4735cd5b-908c-5bdd-b07f-009ca18df1f2","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field c315ee9e-318e-4ca6-a804-a965014f8ec1 --><h3>Adverse effects</h3><!-- end field c315ee9e-318e-4ca6-a804-a965014f8ec1 -->","summary":"","htmlStringContent":"<!-- begin item c49d7127-de77-4fb9-8436-a965014f8e85 --><!-- begin field 0bf1e666-8c6e-435a-b2f0-a965014f8ec1 --><ul><li><strong>The most common adverse effects of diazepam relate to its sedative effect </strong>and include drowsiness and decreased concentration. People who are taking benzodiazepines and drive should be given the following advice:<ul><li>It is an offence to drive after taking diazepam if you feel drowsy, dizzy, unable to concentrate, or make decisions.</li><li>It is an offence to drive if you have more than a specified amount of benzodiazepine in your body, whether your driving is impaired or not.<ul><li>Roadside saliva screening tests in the UK test for certain drugs that impair driving. If you have a positive roadside drug test for benzodiazepines, the police may ask you to provide a blood sample to measure the amount of benzodiazepine in your body.</li><li>If you are found to have more than the specified amount of benzodiazepine in your body, as long as your driving is not impaired, and you are taking your medicine on the advice of a doctor or pharmacist, you will be able to raise a statutory 'medical defence' and the police may not prosecute you.</li><li>It may be helpful to keep evidence that you are taking a benzodiazepine in accordance with medical advice with you while you are driving. Suitable evidence may include: your medication box with the pharmacy label on, or the other half of your prescription with the list of medicines prescribed by your doctor.</li></ul></li></ul></li><li><strong>Other adverse effects include:</strong><ul><li>Headache, vertigo, tremor, slurred speech, decreased libido, erectile dysfunction, gynaecomastia, and obstructive sleep apnoea syndrome.</li><li>Paradoxical effects such as talkativeness, excitement, irritability, aggression, antisocial behaviour, and suicidal ideation.</li><li>Tolerance and dependence (these can develop over time).</li><li>Withdrawal syndrome.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Sweetman, 2011a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Taylor et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">BNF 76, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">DVLA, 2018</a>]</p><!-- end field 0bf1e666-8c6e-435a-b2f0-a965014f8ec1 --><!-- end item c49d7127-de77-4fb9-8436-a965014f8e85 -->","subChapters":[]},{"id":"b5c9dda1-27d8-5c9b-a2a2-3e45245206e4","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 1587d053-b02f-4adc-83c1-a965014f9b99 --><h3>Drug interactions</h3><!-- end field 1587d053-b02f-4adc-83c1-a965014f9b99 -->","summary":"","htmlStringContent":"<!-- begin item d81cf05d-f7d4-4455-97ac-a965014f9b3c --><!-- begin field 9b915b75-1d9e-4461-ba3e-a965014f9b99 --><ul><li><strong>Drug interactions with diazepam include:</strong><ul><li>Alcohol and opioids — advise against concomitant use with diazepam. Alcohol and opioids can induce lethal sedation by potentiating the effects of diazepam.</li><li>Antihypertensives, vasodilators, and diuretics — be aware that concomitant use with diazepam may enhance the hypotensive effects of these drugs.</li><li>Drugs that inhibit cytochrome P450 enzyme (for example cimetidine, ciprofloxacin, azole antifungals, and oestrogens) — avoid concomitant use with diazepam. The metabolism of diazepam is mediated by cytochrome P450 isoenzymes; concomitant use with P450 inhibitors can result in increased serum levels of diazepam leading to increased effect.</li><li>Drugs that induce cytochrome P450 enzyme (for example, St John's Wort and rifampicin) — be aware that cytochrome P450 inducers can accelerate hepatic elimination of diazepam and decrease its action. Dose adjustment of diazepam may be needed.</li><li>HIV protease inhibitors (ritonavir and indinavir) — concomitant use with diazepam is contraindicated. The interactions between HIV protease inhibitors and benzodiazepines are variable; however, the manufacturers of ritonavir and indinavir advise that concurrent use with diazepam is contraindicated.</li><li>Modafinil — monitor for adverse effects of diazepam as modafinil may increase the effects of diazepam. Dose adjustments of diazepam may be needed.</li><li>Phenytoin — monitor phenytoin concentrations as concomitant use with diazepam may increase or decrease serum concentrations of phenytoin.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Preston, 2016</a>]</p><!-- end field 9b915b75-1d9e-4461-ba3e-a965014f9b99 --><!-- end item d81cf05d-f7d4-4455-97ac-a965014f9b3c -->","subChapters":[]},{"id":"b514d91b-9cda-5370-b30e-1b841965d9e5","slug":"switching-to-diazepam","fullItemName":"Switching to diazepam","depth":3,"htmlHeader":"<!-- begin field 20c31f60-a4e6-40ea-a2ea-a965014fe41f --><h3>Switching to diazepam</h3><!-- end field 20c31f60-a4e6-40ea-a2ea-a965014fe41f -->","summary":"","htmlStringContent":"<!-- begin item 7a4e8ef0-7eaf-4de7-9da4-a965014fe2e2 --><!-- begin field ae90f1fb-d4c2-4164-a3ee-a965014fe41f --><ul><li><strong>Information on the approximate dose equivalents of diazepam for a number of benzodiazepines and z-drugs, as well as some examples of switching schedules are shown below.</strong> <strong>Be aware that this information should only be used as a guide.</strong> <strong>Exact dose substitution is not possible, due to:</strong><ul><li>Wide variation in the half-life and response to these drugs (such as the degree of sedation) between different individuals (for example, the elderly and people with hepatic impairment).</li><li>Differences in potency between different benzodiazepines and z-drugs.</li><li>Consequently, a complete dose substitution may not always be required, depending on the individual response (to avoid excessive sedation).</li></ul></li><li><strong>Switching to diazepam is best carried out gradually, usually in a stepwise fashion. </strong>Diazepam is available in a variety of strengths (2 mg, 5 mg, and 10 mg) and formulations (scored tablets or liquid) to facilitate switching. Consider making the first switch in the night-time dose to avoid daytime sedation.</li><li><strong>Dose withdrawal may be started when conversion to diazepam is complete.</strong></li><li><strong>Diazepam 5 mg is approximately equivalent to </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Ashton, 2002b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Lader et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Sweetman, 2011b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Taylor et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Clinical guidelines on drug misuse and dependence update 2017 independent expert working group, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">BNF 76, 2018</a>]<strong>:</strong><ul><li>Zolpidem 10 mg</li><li>Zopiclone 7.5 mg</li><li>Temazepam 10 mg</li><li>Oxazepam 10 mg to 15 mg</li><li>Nitrazepam 5 mg</li><li>Lormetazepam 0.5 mg to 1.0 mg</li><li>Lorazepam 0.5 mg</li><li>Loprazolam 0.5 mg to 1.0 mg</li><li>Clonazepam 0.25 mg</li><li>Clobazam 10 mg</li><li>Chlordiazepoxide 12.5 mg to 15 mg</li><li>Alprazolam 0.25 mg</li></ul></li><li><strong>Examples of switching schedules from the three commonest hypnotics to diazepam </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Ashton, 2002b</a>]<strong>:</strong><ul><li><strong>From temazepam 10 mg to diazepam 5 mg:</strong><ul><li>Week 1: convert temazepam 10 mg straight to diazepam 5 mg.</li></ul></li><li><strong>From temazepam 20 mg to diazepam 10 mg:</strong><ul><li>Week 1: convert temazepam 20 mg to temazepam 10 mg and diazepam 5 mg.</li><li>Week 2: convert remaining temazepam 10 mg to diazepam 5 mg, giving a total diazepam dose of 10 mg daily.</li></ul></li><li><strong>From nitrazepam 5 mg to diazepam 5 mg:</strong><ul><li>Week 1: convert nitrazepam 5 mg straight to diazepam 5 mg.</li></ul></li><li><strong>From nitrazepam 10 mg to diazepam 10 mg:</strong><ul><li>Week 1: convert nitrazepam 10 mg to nitrazepam 5 mg and diazepam 5 mg.</li><li>Week 2: convert remaining nitrazepam 5 mg to diazepam 5 mg, giving a total diazepam dose of 10 mg daily.</li></ul></li><li><strong>From zopiclone 7.5 mg to diazepam 5 mg:</strong><ul><li>Week 1: convert zopiclone 7.5 mg straight to diazepam 5 mg.</li></ul></li><li><strong>From zopiclone 15 mg to diazepam 10 mg:</strong><ul><li>Week 1: convert zopiclone 15 mg to zopiclone 7.5 mg and diazepam 5 mg.</li><li>Week 2: convert remaining zopiclone 7.5 mg to diazepam 5 mg, giving a total diazepam dose of 10 mg daily.</li></ul></li></ul></li><li><strong>Example of a conversion of an anxiolytic (lorazepam 1 mg three times daily) to diazepam </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/benzodiazepine-z-drug-withdrawal/references/\">Ashton, 2002b</a>]<strong>:</strong><ul><li><strong>Week 1:</strong><ul><li>Morning: lorazepam 1 mg.</li><li>Midday: lorazepam 1 mg.</li><li>Evening: lorazepam 1 mg.</li></ul></li><li><strong>Week 2:</strong><ul><li>Morning: lorazepam 1 mg.</li><li>Midday: lorazepam 1 mg.</li><li>Evening: lorazepam 0.5 mg plus diazepam 5 mg.</li></ul></li><li><strong>Week 3:</strong><ul><li>Morning: lorazepam 0.5 mg plus diazepam 5 mg.</li><li>Midday: lorazepam 1 mg.</li><li>Evening: lorazepam 0.5 mg plus diazepam 5 mg.</li></ul></li><li><strong>Week 4:</strong><ul><li>Morning: lorazepam 0.5 mg plus diazepam 5 mg.</li><li>Midday: lorazepam 1 mg.</li><li>Evening: diazepam 10 mg.</li></ul></li><li><strong>Week 5:</strong><ul><li>Morning: diazepam 10 mg.</li><li>Midday: lorazepam 1 mg.</li><li>Evening: diazepam 10 mg.</li></ul></li><li><strong>Week 6:</strong><ul><li>Morning: diazepam 10 mg.</li><li>Midday: lorazepam 0.5 mg plus diazepam 5 mg.</li><li>Evening: diazepam 10 mg.</li></ul></li><li><strong>Week 7:</strong><ul><li>Morning: diazepam 10 mg.</li><li>Midday: diazepam 10 mg.</li><li>Evening: diazepam 10 mg.</li></ul></li><li><strong>Week 8:</strong><ul><li>Start diazepam withdrawal.</li></ul></li></ul></li><li><strong>For information on switching for other benzodiazepines or z-drugs, see the <a data-hyperlink-id=\"47023d77-2b48-4a30-b7ae-a965014f306a\" href=\"https://www.benzo.org.uk/manual/bzsched.htm\">Ashton Manual</a> (available online at <a data-hyperlink-id=\"c287db07-a99d-4b8c-80a3-a965014f3090\" href=\"https://www.benzo.org.uk/\">www.benzo.org.uk</a>).</strong></li></ul><!-- end field ae90f1fb-d4c2-4164-a3ee-a965014fe41f --><!-- end item 7a4e8ef0-7eaf-4de7-9da4-a965014fe2e2 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}